News

The Commonwealth Fund5d
Medicare Drug Price Negotiations: All You Need to Know
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
American Hospital Association4h
HHS says pricing targets identified for drug manufacturers to meet ‘most favored nation’ requirements
The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...
US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...
Health Affairs5d
Administration Releases Medicare Drug Price Negotiation Program Draft Guidance For 2028
The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...
Las Vegas Sun2d
The long road to lower drug prices
President Donald Trump signed an executive order Monday aiming to significantly reduce prescription drug prices in the United ...
JD Supra7d
Medicare Drug Price Negotiation Program: The Inflation Reduction Act “Pill Penalty” and Other IRA Reforms on the Horizon for 2026
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...
1BMY, JNJ : CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
Health Affairs8d
In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single Source Drug’
Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...
The American Journal of Managed Care4d
Specialty Drug Users to Gain Relief Under Medicare Reforms
A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...
National Law Review8d
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
HealthLeaders Media7d
Medicare lays out timeline for third round of drug price negotiations
CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...